Natural History of the Remnant Pancreatic Duct after Pancreatoduodenectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm

New main duct dilation in the pancreatic remnant after pancreatoduodenectomy for IPMN is common, occurring in 27% of the patients. The duration of surveillance is the main factor associated with remnant PD dilation, suggesting that this is likely a physiologic phenomenon. Although recurrence of IPMN in the remnant is often suspected, only 0.8% of patients develop an invasive carcinoma in the pancreatic remnant requiring completion pancreatectomy.

Authors

Institutions

Publication Details

Journal
Annals of Surgery
Published
2024-09-03
DOI
https://doi.org/10.1097/sla.0000000000006519
Citations
2
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Natural History of the Remnant Pancreatic Duct after Pancreatoduodenectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm

Thilo Hackert, M. Del-Chiaro, Greg D. Sacks, Giampaolo Perri et al.
2 citations
Annals of Surgery
Pancreatic and Hepatic Oncology Research
0.57
article

Natural History of the Remnant Pancreatic Duct after Pancreatoduodenectomy for Non-Invasive Intraductal Papillary Mucinous Neoplasm

Thilo Hackert, M. Del-Chiaro, Greg D. Sacks, Giampaolo Perri, Darío M. Rocha-Castellanos, C. Max Schmidt, Max Heckler, Giovanni Marchegiani, Rachel C. Kim, Michael J. Kirsch, Brian K. P. Goh, Alex M. Roch, Julie Périnel, Richard D. Schulick, Jin‐Young Jang, Hye‐Sol Jung, Eugene P. Ceppa, Christopher L. Wolfgang, Roberto Salvia, Mustapha Adham, Carlos Fernández del Castillo
article en
2 citations

Abstract

New main duct dilation in the pancreatic remnant after pancreatoduodenectomy for IPMN is common, occurring in 27% of the patients. The duration of surveillance is the main factor associated with remnant PD dilation, suggesting that this is likely a physiologic phenomenon. Although recurrence of IPMN in the remnant is often suspected, only 0.8% of patients develop an invasive carcinoma in the pancreatic remnant requiring completion pancreatectomy.

Annals of Surgery
University of Verona (IT), University of Padua (IT), Universität Hamburg (DE), Heidelberg University (DE), University Hospital Heidelberg (DE), Seoul National University Hospital (KR), Massachusetts General Hospital (US), Ta Solutions (China) (CN), Hospices Civils de Lyon (FR), University Medical Center Hamburg-Eppendorf (DE), National University Hospital (SG), Indiana University School of Medicine, University of Colorado Anschutz Medical Campus (US), Indiana University – Purdue University Indianapolis (US), New York University (US)
Good health and well-being
Openalex Percentile: Top 28%
Pancreatic and Hepatic Oncology Research
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.